BioStock: Evaxion Biotech awarded by Frost & Sullivan for its AI platform

Danish Evaxion Biotech has been awarded the Frost & Sullivan 2021 Enabling Technology Leadership Award for the development of its proprietary AI-immunology platforms. According to the research firm, Evaxion “sets an impressive benchmark to follow in the AI-enabled drug discovery space”. BioStock reached out to the company’s CEO Lars Wegner to get a comment.

Read the full article at biostock.se:

https://www.biostock.se/en/2021/10/evaxion-biotech-awarded-by-frost-sullivan-for-its-ai-platform/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se